Gene expression analysis of individual Brca1 mammary tumors and their subsequent passages in vivo revealed substantial heterogeneity in gene expression [40], as predicted by differences in frequency and identity of cancer stem cell populations in cell lines derived from these tumors. The gene discussed is BRCA1; the disease is breast cancer.